ArticleProceedings of the National Academy of Sciences of the United States of America2022

Assessment of a quadrivalent nucleoside-modified mRNA vaccine that protects against group 2 influenza viruses.

Meagan McMahon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.